ADMA Biologics (ADMA) Tops Q3 EPS by 8c
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
ADMA Biologics (NASDAQ: ADMA) reported Q3 EPS of ($0.34), $0.08 better than the analyst estimate of ($0.42).
For earnings history and earnings-related data on ADMA Biologics (ADMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Credit Suisse Downgrades Himax Technologies (HIMX) to Neutral
- Renasant Corp. (RNST) Misses Q4 EPS by 1c
- Hancock Holding (HBHC) Tops Q4 EPS by 3c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!